Sitemap
- Company
- Products
- Nasal Delivery
- Clinical Trials
- R & D
- News & Media
- Press Releases
- February 14, 2012 - OptiNose Announces First Patient Enrolled in Phase III Study of Sumatriptan Powder Delivered Intranasally with Innovative Bi-directional Device
- February 2, 2012 - OptiNose Files Investigational New Drug Application to use Sumatriptan Delivered with its Novel Drug Delivery Technology
- August 1, 2011 - OptiNose Announces Additional Leadership Team Members
- May 23, 2011 - OptiNose Bi-Directional Drug Delivery Technology Wins Innovation Award for Potential Benefits of Nose to Brain Application
- November 3, 2010 - OptiNose Receives Nearly $489,000 Grant Award under U.S. Government Qualifying Therapeutic Discovery Project Program
- October 28, 2010 - Rapid Absorption Rate Alone May Not Explain Efficacy in Migraines of Sumatriptan Delivered with OptiNose's Novel Drug Delivery Technology
- October 20, 2010 - New Data Show Therapeutic Benefits in Chronic Rhinosinusitis Patients Using Fluticasone Delivered by OptiNose’s Novel Delivery Technology
- August 10, 2010 - OptiNose Announces Publication of Positive Subgroup Analysis Evaluating Efficacy of Fluticasone Delivered with Novel Drug Delivery Technology
- June 7, 2010 - Avista Capital Partners Commits $48.5 Million to OptiNose to Develop an Innovative Nasal Drug Delivery Technology Slated to Begin Phase III Trials
- December 1, 2009 - New Data on Highly Effective Treatment for Chronic Rhinosinusitis with Nasal Polyps
- April 17, 2009 - Optinose Presents New Data on Highly Effective Treatment for Chronic Rhinosinusits
- April 17, 2009 - Upcoming Event -17 April 2009 - Rhinology World 2009 Presentation
- April 1, 2009 - Upcoming Event - 1 April 2009 - Nasal Drug Delivery Conference Presentation
- September 20, 2008 - Upcoming Event - 20 September 2008 - American Rhinology Association Presentation
- September 19, 2008 - OptiNose Presents Data On Highly Effective Nasal Polyp Treatment
- June 29, 2008 - American Headache Society - Phase II Migraine (Poster PDF, 652KB)
- June 28, 2008 - OptiNose Presents Data on Highly Effective Migraine Treatment
- April 18, 2008 - American Academy of Neurology - Phase I Migraine (Poster PDF, 1.1MB)
- April 17, 2008 - OptiNose Nasal Delivery of Sumatriptan Proves as Effective as Subcutaneous Injection
- March 23, 2008 - Phase I Human Insulin Data
- December 5, 2007 - New Phase II Data for Nasal Polyposis
- November 5, 2007 - OptiNose Completes Phase II Study in Migraine
- October 5, 2007 - OptiNose Initiates Phase II Study in Chronic Rhinosinusitis
- December 20, 2006 - OptiNose Completes Phase I Study with Triptan
- October 23, 2006 - OptiNose Completes Phase I Study with Topical Steroid
- Peer Reviewed Journal Publications
- Articles
- Press Coverage
- Media Kit
- Press Releases
